Monday, June 08, 2009

PR Fluff

That's what this post on generic drugs vs. name brand prescriptions at the Detroit Free Press is. I'd write more, but I've got to get to work. Suffice it to say, the only people that stand to profit from this type of article are the manufacturers of the generic drug that can charge the premium price.

No comments: